N/A N=58 In Home Assessment of Three Anti-Snoring Devices, a Cross Over Study
Snoring
Primary: Bed Partners' Rating of Sleep Disturbance Due to Partner Snoring — 5.0; 3.8; 4.4 units on a scale — p=<.001
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=604 OTC Mouthpiece for Snoring
Snoring
Primary: Snoring Severity Scale — -4.1 units on a scale — p=< 0.0001
Phase 2 N=100 Mandibular Advancement vs Home Treatment for Primary Snoring
Snoring
Primary: Percent Responders of Clinical Global Impression of Improvement Scale - Partner — 91; 58 percent of snorer responders
N/A N=25 Anti-Snoring Appliances and Airway Manipulation in Patients Undergoing Anesthetic Sedation
Airway Obstruction · Snoring · Sedation Complication
Primary: Combined Total Number of Airway Interventions During an Anesthetic Sedation Case — 7; 5 Airway Interventions
N/A N=18 Study Will Test the Theory That Training With the Facial-Flex Exercise Device Will Improve Snoring in Patients
Primary Snoring · Sleep Apnea
Primary: Snore Index — 348.4; 186.2 snores per hour of monitoring — p=0.02
N/A N=30 Analysis of Snore Sound Following Minimal Invasive Surgery in Sleep-disordered Breathing Patients
Primary Snoring · Obstructive Sleep Apnea
Primary: Change in VAS Score After MIS — -1.4; -3.3 units on a scale — p=<0.05
N/A N=186 Adenotonsillectomy for Obstructive Sleep-Disordered Breathing in Childhood:The Chania Community Oximetry-Based Study
Sleep Disordered Breathing · Obstructive Sleep Apnea · Snoring
Primary: Change in Number of Subjects Without Oxygenation Abnormalities — 12; 10 Participants — p=0.54
N/A N=32 A Disposable Device NAS to Treat Obstructive Sleep Apnea and Snoring
Obstructive Sleep Apnea · Snoring
Primary: Apnea-Hypopnea Index (AHI) — 30.0 events/hour — p=0.0559
N/A N=42 Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study
Obstructive Sleep Apnea · Snoring
Primary: Adherence to Therapy — 18.4; 26.1 days
Phase 2 N=140 A Pivotal Subjective Sleep Study of a Nasal Dilator (Breathe Right Tan)
Congestion, Nasal
Primary: Change From Baseline in Mean Total Score of the Nocturnal Rhinoconjunctivitis Quality of Life Questionnaire (NRQLQ) for Each Domain (Sleep, Sleep Time, Symptoms on…
N/A N=40 Sleep Apnoea Breathing Record Exploratory Study (SABRES)
Sleep Apnea
Primary: Correlation Between the Trial Device and an Established Device — 0.955 correlation coefficient
N/A N=26 Effect of Added Varnum Mouthpiece on Pharyngeal Collapsibility and Sleep Apnea Severity in Mouth Breathers.
Obstructive Sleep Apnea
Primary: Sleep Apnea Severity as Measured by Apnea-hypopnea Index (AHI) — 16.4; 15.8 Events/hour
Phase 2 N=91 To Characterize the Performance of the Nasal Dilator Strip in Lowering Nasal Resistance During Sleep, Promoting Nasal Route Breathing and Reducing the Signs and Symptoms of Sleep Disordered Breathing in a Group of Chronic Nocturnal Nasal Congestion Sufferers Who Report Trouble With Their Sleep.
Sleep Disordered Breathing · Congestion, Nasal
Primary: Nasal Resistance in Sleeping State : Nasal Resistance Phase — 2.658; 2.202 Centimeter (cm) H2O/liter/sec — p=0.0147
Phase 2 N=20 Effect of Background Noise on Sleep Quality
Sleep Onset Insomnia
Primary: Sleep Onset Latency (Mins) — 13; 19 minutes — p=0.011
N/A N=27 Broadband Sound and Sleep
Noise Exposure
Primary: Time Spent in Slow Wave Sleep and Rapid Eye Movement (N3 + REM) — 188.5532184; 195.9798771; 209.51862074703; 176.4599674 Minutes
N/A N=459 Pediatric Adenotonsillectomy Trial for Snoring
Sleep-Disordered Breathing
Primary: Change From Baseline to 12 Months in Caregiver-reported Behavior Rating Inventory of Executive Function (BRIEF) Global Executive Composite (GEC) T Score — -1.90; -3.08…
N/A N=133 Mechanisms of Upper Airway Obstruction
Obstructive Sleep Apnea
Primary: Pharyngeal Critical Pressure (Pcrit) — 1.26; -1.42; -1.06 cm H2O — p=.80
Phase 2 N=61 Exploratory Subjective Sleep Study of a Prototype Nasal Dilator
Sleep Disorders · Congestion, Nasal
Primary: Change From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS) in Q1, Q3, Q17 and Q18 at Day 7 — -0.911; -0.694; -1.032; -1.004 Score on a…
N/A N=144 Evaluating the Relationship Between Sleep-Disordered Breathing and Daytime Alertness
Sleep Apnea, Obstructive
Primary: Subjective Sleepiness — 11.8; 10.2; 9.9 units on a scale
N/A N=40 Effects of Myofunctional Therapy With an Application in Severe Apnea/Hypopnea Sleep Obstructive Syndrome (MTASSAOS)
Obstructive Sleep Apnea-hypopnea Syndrome
Primary: Apnea Hypopnea Index (AHI) — 44.77; 47.36; 20.88; 35 events per hour — p=<0.001
N/A N=31 Hemodynamics Response to Upper Airway Obstruction in Marfan Syndrome
Sleep-disordered Breathing · Snoring
Primary: Pleural Pressure (Pes) — 9.3; 4.4 mmHg
Phase 2 N=11 DAW1033D in Obstructive Sleep Apnea
Obstructive Sleep Apnea (OSA)
Primary: Apnea Hypopnea Index (AHI, Events/Hour of Sleep) — 21.6; 37.9 events/hour of sleep — p=0.56
Phase 2 N=12 Sleep Apnea Treatment With Expiratory Resistance(Provent™)
Sleep Apnea, Obstructive
Primary: Change in AHI — 45; -15.8 events/h
N/A N=317 Obstructive Sleep Apnea in World Trade Center Responders
Obstructive Sleep Apnea
Primary: Adherence to CPAP Pre-crossover — 1; 0.89 Hours/night
N/A N=62 Trial on Oral Appliance Design for Improving Upper Airway Function and Sleep Quality
Obstructive Sleep Apnea
Primary: Respiratory Event Index (REI) at T2 — 12.8; 21.1; 9.3; 13.1 number of events per hour — p=0.152
N/A N=15 Upper Airway Physical Therapy for the Treatment of Obstructive Sleep Apnea
Obstructive Sleep Apnea Syndrome
Primary: Delta of Apnea Hypopnea Index (AHI) as Measured by Polysomnography (PSG) — 4.27 events per hour
Phase 2 N=13 DAW1033B2 in Obstructive Sleep Apnea
Obstructive Sleep Apnea (OSA)
Primary: Apnea Hypopnea Index (AHI, Events/Hour of Sleep) — 33; 20.4 events/hour of sleep — p=0.47
N/A N=89 Sleep Disordered Breathing, Obesity and Pregnancy Study (SOAP)
Obese · Pregnancy · Sleep Disordered Breathing
Primary: Uterine Artery Doppler Mean Pulsatility Index -by Ultrasound — 1.0; 1.0; 1.0; 1.0 Mean PI
N/A N=52 Validation of Sleep Apnea Screening Device
Obstructive Sleep Apnea
Primary: Specificity — 71.4 percentage of true negatives
N/A N=2 Pilot Study of a Self-Supporting Nasopharyngeal Airway in Hypotonia
Sleep Apnea, Obstructive · Hypotonia · Child, Only
Primary: Ability to Tolerate Measured by Percent of Participants With Protocol Goal — 50 percent of participants